Allergan Rallies Ahead Of Q1 Report

Loading...
Loading...

Allergan AGN shares are trading higher by $13 at $214.65 in Monday's session. The company will announce Q1 earnings before the bell on Tuesday.

The issue has tumbled since a planned merger with Pfizer Inc PFE was scrapped on April 5. The following day drop declined all the way to $236.55 and traded as low as $195.50 in before rebounding to close at $201.65.

The catalyst for today's rally besides some short covering ahead of the report is the announcement that a Phase III study for Ulipristal Acetate in the treatment of uterine fibroids met all co-primary and secondary endpoints.

Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...